Abstract
Social work authors have presented superficial appraisals of atypical neuroleptic (antipsychotic) drugs used to treat schizophrenia. This article presents a critical overview of clinical trials and research strategies involving conventional and atypical drugs. It identifies 14 distinct methodological and conceptual failings and neglected research directions. These flaws raise serious doubts about the scientific justifications for the widespread use of neuroleptics. Implications for a critical social work education stance about psychopharmacology are discussed. Findings from psychopharmacotherapy studies cannot be taken at face value: social work educators must scrutinize the adherence of the research enterprise to the scientific method and situate its findings in their historical, ideological, and political-economic contexts.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
